Analysis Of The Development Status And Industry Trends Of The Health Industry Of Cistanche Tubulosa

Against the backdrop of multiple policies such as upgrading national health consumption, revitalizing the traditional Chinese medicine industry, ecological governance, and rural revitalization, the medicinal and edible herbal nourishing industry has entered a period of rapid development. Cistanche tubulosa, known as the "golden desert", is a traditional and precious Chinese medicinal herb with multiple health benefits such as tonifying the kidneys, nourishing essence, moistening dryness and intestines, and regulating immunity. In 2023, Cistanche tubulosa will officially improve its medicinal and edible homology attribute recognition, completely breaking the scene limitations of industrial development, quickly integrating into the big health industry system, and forming a complete industrial system of "ecological planting, deep processing, diversified applications, and market circulation". At present, the Cistanche tubulosa industry has transformed from a single supply of traditional Chinese medicine raw materials to a diversified health track covering health food, functional food, beauty and skincare, and health care services, becoming an important growth pole for the characteristic pillar industry and traditional Chinese medicine health industry in the northwest desert region. 

Core driving background of industrial development

(1) Policy dividends continue to be released, and industries are developing in compliance

In recent years, the country has attached great importance to the inheritance, innovation, and development of traditional Chinese medicine, as well as the cultivation of industries related to medicine and food. Several policies, such as the Implementation Plan for the Major Project of Revitalizing and Developing Traditional Chinese Medicine, have clearly supported the standardized cultivation and industrialization of characteristic Chinese medicinal materials. The core policy breakthrough lies in the expansion of the scope of the medicinal food homologous catalog of Cistanche tubulosa in 2023, which officially clarifies its qualification for ordinary food additives and completely solves the industry pain point that Cistanche tubulosa can only be used as a medicinal herb and cannot be widely used in daily food for a long time. After the implementation of the policy, the variety of food related to Cistanche tubulosa has surged from over a hundred to over a thousand, and the industry access threshold has been optimized, and compliance has been greatly improved. At the same time, major production areas such as Xinjiang and Inner Mongolia have introduced special planting subsidies, technical support, and market cultivation policies, established standardized industrial parks and trading platforms, and laid a solid policy foundation for the large-scale and standardized development of industries. In addition, the industrial model of "Red Willow Symbiosis, Sand Control and Income Increase" of Cistanche tubulosa is in line with the strategy of desertification control and rural revitalization, and has received policy support from multiple fields such as ecology, agriculture, and traditional Chinese medicine.

The villagers of Hetian Village in Xinjiang are digging and harvesting Cistanche tubulosa 

(2) Upgrading health consumption and continuously expanding market demand

With the normalization of sub-health problems among the population and the deepening of the aging population, the public's demand for health preservation has shifted from traditional disease treatment and regulation to daily preventive health care. The concept of natural herbs and mild nourishing health has deeply penetrated people's hearts. Cistanche tubulosa has mild medicinal properties, is nourishing but not dry, and is suitable for diverse consumption scenarios such as middle-aged and elderly health care, sub-health regulation for the workplace, male health preservation, and intestinal care, accurately matching the current trend of refined and normalized health consumption. Compared to traditional tonics such as ginseng and deer antler, Cistanche tubulosa has a higher cost performance ratio, is more suitable for a wider range of people, and has no excessive nourishing side effects, gradually becoming one of the preferred daily nourishing categories for the public. At the same time, the rise of young consumer groups and the explosion of demand for convenient and functional health products have driven the transformation of Cistanche tubulosa from traditional Chinese medicinal herbs and decoctions to lightweight products such as beverages, candies, meal replacements, and skincare, opening up a new consumer market.

cistanche supplement near me

(3) Ecological industry integration, supply system becoming increasingly mature

Cistanche tubulosa is a parasitic plant that grows on sand plants such as red willows and red willows. Artificial cultivation has both ecological management and economic output value. After 20 years of technological iteration, China has completely rid itself of the dependence on wild Cistanche tubulosa resources and achieved full coverage of large-scale artificial planting. This not only protects endangered wild germplasm resources, but also builds an eco-friendly industrial model through the utilization of desertification land resources. At present, the main production areas have formed a closed-loop system of "sand control+planting+income increase+industry", providing core guarantees for the sustained and stable supply of industries.

Scale and overall pattern of industrial market

Driven by policies, demand, and technology, the domestic health industry of Cistanche tubulosa continues to maintain double-digit growth, far exceeding the average level of the traditional Chinese medicine industry. According to industry research data, the overall market size of China's Cistanche tubulosa industry will reach 4.86 billion yuan in 2025, a year-on-year increase of 12.3%, while the overall growth rate of the traditional Chinese medicine industry during the same period is only 7.8%. Among them, the functional food and health product sectors have grown the fastest, with the market size of Cistanche tubulosa functional food reaching 8.64 billion yuan in 2024, a year-on-year increase of 34.2%, becoming the core growth engine of the industry. It is expected that the overall scale of the industry will exceed 5.46 billion yuan by 2026, and the compound annual growth rate will remain above 15% in the next five years, entering a stage of high-quality expansion as a whole.

From a regional perspective, China's Cistanche tubulosa industry exhibits highly concentrated regional characteristics, with Xinjiang and Inner Mongolia, the two major production areas, contributing over 90% of the country's production capacity and output value, forming two core industrial clusters. Alxa, Inner Mongolia, is the largest production area and trading hub of Cistanche tubulosa in China. It has built the world's largest professional trading market for Cistanche tubulosa, with an annual transaction volume of over 3 billion yuan, gathering enterprises in the entire chain of planting, processing, research and development, and trade. Relying on vast desert land resources, Xinjiang ranks first in the country in terms of planting area and yield. By 2023, the artificial planting area of Cistanche tubulosa in China will reach 186000 hectares, with a yield exceeding 52000 tons, of which Xinjiang production areas account for over 60%. At present, the two core production areas have gradually transformed from exporting single raw materials to integrating deep processing, brand operation, and cultural tourism and health care, and the regional industrial cluster effect continues to be prominent.

Abundant harvest of Cistanche tubulosa

From the perspective of market structure, the industry presents a pattern of "primary products as the mainstay, and rapid growth of high-end products". At present, basic products such as primary raw materials, slices, and dry powders still dominate the market, mainly supplying the medicinal material circulation market and low-end processing areas. But with the upgrading of extraction and purification technology, the market share of high-purity extracts and functional deep-processed products has rapidly increased. Among them, the market share of high-purity extract products with a content of pineal glycoside ≥ 20% will increase to 28% by 2025, doubling compared to 2020. However, currently the high-end production capacity supply in the industry is insufficient, and the effective high-purity production capacity can only meet about 45% of the market demand. The supply and demand gap of high-end products continues to exist, and there is huge room for industrial structural upgrading.

The current development status of the entire industry chain

(1) Upstream planting end: scale popularization, standardization needs to be improved

Upstream cultivation is the fundamental support for the health industry of Cistanche tubulosa. At present, China has fully achieved large-scale artificial cultivation, and wild Cistanche has basically withdrawn from the commercial circulation market. The protection of germplasm resources and industrial development have achieved a two-way balance. The planting mode is mainly based on the symbiotic planting of "Red Willow and Cistanche tubulosa", which is suitable for the desert and semi-desert land in northwest China, achieving dual empowerment of ecological restoration and agricultural income increase. After years of promotion, standardized planting demonstration bases have been formed in the main production areas, and planting techniques are becoming increasingly mature. The yield per mu and the content of effective ingredients are steadily increasing.

However, there are still obvious shortcomings in the planting end: firstly, the standardization level of planting is uneven, with a large proportion of individual planting and small-scale bases. There is a lack of unified standards in seed selection, parasitism, field management, harvesting and drying, resulting in significant differences in the effective component content and quality of products from different production areas and batches; Secondly, the problem of germplasm resource degradation has become prominent, with long-term asexual reproduction leading to a decline in the effective components of Cistanche tubulosa in some planting bases and insufficient quality stability; Thirdly, the degree of planting intensification is relatively low, with scattered planting and insufficient refined management in some production areas. The ability to resist natural risks is weak, which restricts the overall upgrading of raw material quality.

(2) Midstream processing end: diverse categories, obvious technological stratification

Midstream processing is the core link for enhancing industrial value and also the most significant area of industrial transformation in recent years. With the implementation of the qualification for medicinal food homology, the processing category of Cistanche tubulosa has achieved a comprehensive breakthrough, completely breaking away from the single form of traditional medicinal materials and forming three core product systems. One is traditional health and wellness products, including sliced Cistanche tubulosa, dry powder, decoction pieces, decoctions, etc., targeting the traditional Chinese medicine market and meeting the consumption needs of offline pharmacies and traditional Chinese medicine clinics; The second is a new type of functional food, covering convenient products such as solid beverages, compressed candies, compound soup drinks, Cistanche camel milk powder, Cistanche coffee, etc., suitable for the daily health scenes of young consumer groups; Third, beauty skin care and health care derivatives, relying on the anti-oxidation and nourishing effects of Cistanche tubulosa, develop facial mask, essence, skin care products, etc., and extend the industrial value chain. At present, top enterprises can deeply process more than 50 product categories, and the added value of deeply processed products is more than 10 times higher than that of primary raw materials.

Cistanche Oral Liquid

The processing technology presents obvious hierarchical characteristics: small and medium-sized processing enterprises mainly engage in rough processing, only performing simple drying, slicing, and polishing, resulting in severe product homogenization and low added value; Top brands and high-tech enterprises focus on deep processing, using advanced technologies such as low-temperature extraction, concentration and purification, and molecular separation to solve the pain points of traditional edible methods where effective ingredients are difficult to dissolve in water and have low absorption rates. They develop refined products with high purity and high absorption rates. Overall, the trend of upgrading processing technology in the industry is clear, with refinement, functionalization, and high purification becoming the core development directions.

(3) Downstream market end: channel expansion, comprehensive penetration of consumer scenarios

The downstream consumer market has formed a circulation system that integrates online and offline channels and covers multiple scenarios. The offline channels mainly include wholesale markets for traditional Chinese medicinal materials, physical pharmacies, health and wellness stores, and supermarket counters, focusing on traditional tonics and elderly health and wellness consumption; Online channels, relying on e-commerce platforms, live streaming sales, and social e-commerce, have rapidly emerged as the core channel for promoting new products and cultivating young users. Convenient and small packaged functional online sales of Cistanche tubulosa continue to soar.

From the perspective of consumer groups, the consumption structure continues to diversify, breaking the traditional single consumption pattern of middle-aged and elderly people. At present, the main consumer groups are divided into three categories: the first is the middle-aged and elderly group, whose core needs are to tonify the kidneys and strengthen the foundation, moisten the intestines and promote bowel movements, and regulate immunity; The second group is young people in the workplace, who focus on daily light health care to address issues such as staying up late, high stress, and sub-health; The third group is the young consumer group, who prefer convenient and snack like products derived from Cistanche tubulosa, and there is a significant trend towards younger consumption in health preservation. At the same time, the products of Cistanche tubulosa are gradually going abroad, and their recognition in Southeast Asian, European, and American markets continues to increase, steadily enhancing their international competitiveness.

Desert ginseng-Improve immunity

Click here to view Cistanche Enhance Immunity products

【Ask for more】 Email:cindy.xue@wecistanche.com / WhatsApp: 0086 18599088692 / WeChat: 18599088692

Existing core problems and development pain points in the industry

(1) The industry standardization system is not perfect, and the quality varies greatly

At present, there is no unified national standard and industry norms for the entire chain of the Cistanche tubulosa industry, and the standards for various links from planting, harvesting, processing to testing and circulation are not unified. The lack of unified germplasm screening, field management, and harvesting time standards at the planting end leads to significant differences in raw material quality; The processing end is mixed with rough and deep processing enterprises, and some small and medium-sized enterprises have problems such as simple processing technology, excessive impurities, and substandard effective ingredients; The lack of a unified quality grading standard on the testing end has led to a widespread phenomenon of inferior products being passed off as good and mixed quality in the market, seriously affecting the overall reputation of the industry and consumer trust. At the same time, the construction of a product traceability system lags, and most small and medium-sized brands cannot achieve full traceability of origin, processing, and quality inspection, making quality control difficult.

(2) Serious industrial homogenization and insufficient supply of high-end production capacity

The industry as a whole presents a structural contradiction of "low-end overcapacity and high-end supply shortage". Small and medium-sized enterprises are clustered in the market, with most focusing on low-threshold primary raw materials and ordinary processed products. Product styles, functions, and packaging are highly homogeneous, and the low-end market competition in the industry is fierce, even falling into low-price competition. However, the supply of high-purity extracts, functional customized products, and high-end health and wellness derivatives with high technological barriers is seriously insufficient, and the demand in the high-end market cannot be fully met. At the same time, the overall R&D investment in the industry is low, and most enterprises lack independent R&D capabilities. The speed of product innovation iteration is slow, and the core technology barriers are insufficient, which restricts the high-end upgrading of the industry.

(3) Weak brand influence and limited market awareness

Compared with popular medicinal and edible products such as goji berries and astragalus, the branding development of Cistanche tubulosa lags, and the industry lacks nationally renowned top brands. Most enterprises mainly engage in OEM production, raw material supply, and regional sales, with extremely low brand premium ability. At the same time, the public's understanding of Cistanche tubulosa is one-sided. Traditional knowledge is limited to male nourishing medicinal herbs, ignoring its diverse values such as moisturizing the intestines, regulating immunity, anti-fatigue, and daily health care, resulting in limited consumption scenarios and low market penetration rates among women and young people. In addition, there is insufficient market education in the industry, and consumers lack awareness of product quality identification, consumption methods, and adaptation scenarios, which hinders the expansion of market scale.

(4) Insufficient synergy in the industrial chain and low added value of the industry

At present, the synergy between the upstream and downstream of the Cistanche tubulosa industry is weak, and the connection between the planting end, processing end, and brand operation end is loose. Planting farmers and processing enterprises often have loose cooperation, with low coverage of order-based and standardized planting, and insufficient matching between raw material supply and market demand. The linkage between scientific research institutions, enterprises, and production areas is insufficient, the conversion rate of scientific research achievements is low, and a large number of high-quality R&D technologies cannot be industrialized. The overall industry is still dominated by the circulation of primary products, with a low proportion of high-value-added links such as deep processing, brand operation, and health care services. The overall profit space of the industry has been compressed, and the great health value of Cistanche tubulosa has not been fully explored.

Future Development Trends of the Industry

(1) Standardization and normalization development accelerate industry reshuffle

In the future, the industry will gradually establish a standardized system for the entire chain from planting, processing, testing to circulation. Standardized planting at the place of origin, standardized processing of products, and standardized testing of quality will become industry access standards. With increasingly strict regulation, low-quality, unqualified, and homogeneous small and medium-sized production capacity will gradually be cleared out, industry reshuffling will accelerate, and resources will be concentrated towards large-scale, standardized, and high-tech enterprises. At the same time, the origin traceability system will be fully popularized, realizing the full process of product traceability, inspection, and comprehensively improving the quality and credibility of industry products.

(2) Technology drives industrial upgrading, with high-end products becoming mainstream

Relying on advanced technologies such as biological extraction, purification and concentration, and activity retention, the Cistanche tubulosa industry will continue to upgrade towards high purification, functionalization, and refinement. High-purity active ingredient extracts, targeted functional health products, and high-absorption customized products will gradually replace traditional primary products and become the mainstream in the market. Enterprises will increase their R&D investment, focus on ingredient optimization, product innovation, and scenario segmentation, develop exclusive products for different ages, physical conditions, and consumption scenarios, tap into differentiated market value, and solve the problem of homogeneous competition.

(3) Brand building accelerates, market awareness is comprehensively upgraded

The industry will bid farewell to the era of unbranded and low-priced competition, and leading enterprises will accelerate their branding layout to create a national and professional Cistanche tubulosa health brand. At the same time, the industry will continue to carry out market science popularization and education, break the public's single cognition of Cistanche tubulosa, popularize its diverse health and wellness values, expand emerging consumption scenarios such as women's health, intestinal care, and sub-health regulation, broaden consumer groups, and activate incremental markets. The brand marketing system that integrates online and offline will continue to improve, helping products enter the mainstream consumer market.

cistanche powder

(4) Deepening integration of industrial chains and continuous release of industrial value

In the future, the Cistanche tubulosa industry will achieve a full chain integrated development of "planting+processing+research and development+branding+health and wellness+cultural tourism", relying on the ecological resource advantages of the northwest production area, promoting the integrated development of traditional Chinese medicine health and wellness, desert cultural tourism, and rural industries, extending the industrial chain, and enhancing the value chain. At the same time, the internationalization layout of the industry will steadily advance, relying on traditional Chinese medicine culture to go global, enhancing the international market share of Cistanche products, and creating a herbal health industry business card with Chinese characteristics. Under the multiple empowerment of ecological value, economic value, and social value, the health industry of Cistanche tubulosa will continue to maintain high-speed growth and become a core potential track in the field of traditional Chinese medicine health.

Overall, the health industry of Cistanche tubulosa is at a critical stage of transitioning from scale expansion to quality upgrading, from raw material output to brand empowerment, and from a single category to a diversified ecosystem. Despite the current problems of insufficient standardization, serious homogenization, and weak brand power in the industry, driven by policies, demand, and technology, the trend of industrial upgrading is clear, and the future development potential is enormous. It is expected to become a benchmark industry for the integration and development of China's characteristic traditional Chinese medicine health industry and rural characteristic industry.